Efficacy of Interscalene Brachial Plexus Block With Liposomal Bupivacaine for Arthroscopic Shoulder Surgery
Completed · Phase 4
Conditions studied: Shoulder Pain, Rotator Cuff Tear
In brief
The purpose of this study is to compare the quality and duration of pain relief after shoulder surgery provided by a single injection of liposomal bupivacaine versus standard bupivacaine when administered as an interscalene brachial plexus block. It is hypothesized that the liposomal bupivacaine formulation will provide more effective pain relief than standard bupivacaine.
Key facts
- Study ID
- NCT01977352
- Run by
- St. Luke's-Roosevelt Hospital Center
- People needed
- 42
- Starts
- 2014-01-01
- Expected to finish
- 2015-02-01
- Last updated by the study team
- 2018-04-02
Who can join
Age: 17 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- English speaking adults (age >17 years) of American Society of Anesthesiologists (ASA) I-III physical class scheduled for elective arthroscopic shoulder surgery will be eligible to participate regardless of race/ethnicity.
You may not qualify if…
- Subjects will not be eligible for this trial if they report a history of an allergy to a local anesthetic, baseline neurological deficit, a medical condition that would make it difficult to assess sensory distribution or communicate with the staff, a recent history (< 3 months) of drug or alcohol abuse, concomitant opioid therapy, or a preexisting coagulation disorder.
Where it is running
- St. Luke's Roosevelt Hospital Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.